[1]
|
V. H. L. Lee and A. Yamamoto, “Penetration and Enzymatic Barriers to Peptide and Protein Absorption,” Advanced Drug Delivery Reviews, Vol. 4, No. 2, 1990, pp. 171-207. doi:10.1016/0169-409X(89)90018-5
|
[2]
|
J. F. Woodley, “Enzymatic Barriers for GI Peptide and Protein Delivery,” Critical Reviews in Therapeutic Drug Carrier Systems, Vol. 11, 1994, pp. 61-95.
|
[3]
|
J. S. Beck, M. E. Leonowicz and W. J. Roth, “Ordered Mesoporous Mole-cular-Sieves Synthesized by a Liquid- Crystal Template Mechanism,” Nature, Vol. 359, 1992, pp. 710-712. doi:10.1038/359710a0
|
[4]
|
D. E. De Vos, M. Dams and B. F. Sels, “Dielectric Properties of BNT Ferroelectrics in Paraelectric Phase,” Chemical Reviews, Vol. 102, 2002, pp. 3615-3640.
doi:10.1021/cr010368u
|
[5]
|
A. Vinu, M. Miyahara and K. Z. Hossain, “Lysozyme Adsorption onto Mesoporous Materials: Effect of Pore Geometry and Stability of Ad-sorbents,” Journal of Nanoscience and Nanotechnology, Vol. 7, No. 3, 2007, pp. 828-832. doi:10.1166/jnn.2007.511
|
[6]
|
J. Salonen, L. Laitinen and A. M. Kaukonen, “Mesoporous Silicon Microparticles for Oral Drug Delivery: Loading and Release of Five Model Drugs,” Journal of Controlled Release, Vol. 108, No. 2-3, 2005, pp. 362-374.
doi:10.1016/j.jconrel.2005.08.017
|
[7]
|
I. I. Slowing, B. G. Trewyn and S. Giri, “Mesoporous Silica Nanoparticles for Drug Delivery and Biosensing Applications,” Advanced Functional Materials, Vol. 17, No. 8, 2007, pp. 1225-1236.
doi:10.1002/adfm.200601191
|
[8]
|
J. Lu, M. Liong and J. I. Zink, “Mesoporous Silica Nanoparticles as a Delivery System for Hydrophobic Anticancer Drugs,” Small, Vol. 3, No. 8, 2007, pp. 1341- 1346. doi:10.1002/smll.200700005
|
[9]
|
J. Gu, W. Fan and A. Shimojima, “Organic-Inorganic Mesoporous Nanocarriers, Integrated with Biogenic Li-gands,” Small, Vol. 3, No. 10, 2007, pp. 1740-1744.
doi:10.1002/smll.200700311
|
[10]
|
A. Vinu, K. Z. Hossain and K. Ariga, “Recent Advances in Functionalization of Mesoporous Silica,” Journal of Nanoscience and Nanotechnology, Vol. 5, No. 3, 2005, pp. 347-371. doi:10.1166/jnn.2005.089
|
[11]
|
F. Y. Qu, G. S. Zhu and S. Y. Huang, “Effective Controlled Release of Captopril by Silylation of Mesoporous MCM-41,” Physical Chemistry Chemical Physics, Vol. 7, No. 2, 2006, pp. 400-406. doi:10.1002/cphc.200500294
|
[12]
|
P. Horcajada, A. Ra-mila and J. Perez-Pariente, “Influence of Pore Size of MCM-41 Matrices on Drug Delivery Rate,” Microporous and Mesoporous Mater, Vol. 68, No. 1-3, 2004, pp. 105-109.
doi:10.1016/j.micromeso.2003.12.012
|
[13]
|
Y. J. Han, G. D. Stucky and A. Butler, “Mesoporous Silicate Seques-tration and Release of Proteins,” Journal of the American Chemical Society, Vol. 121, No. 42, 1999, pp. 9897-9898. doi:10.1021/ja992138r
|
[14]
|
Y. F. Zhu, J. L. Shi and Y. S. Li, “Storage and Release of Ibuprofen Drug Molecules in Hollow Mesoporous Silica Spheres with Modified Pore Surface,” Microporous and Mesoporous Mater, Vol. 85, No. 1-2, 2005, pp. 75-81.
doi:10.1016/j.micromeso.2005.06.015
|
[15]
|
D. R. Radu, C.Y. Lai and K. Jeftinija, “A Polyamidoamine Dendri-mer-Capped Mesoporous Silica Nanosphere-Based Gene Transfection Reagent,” Journal of the American Chemical Society, Vol. 126, No. 41, 2004, pp. 13216-13217. doi:10.1021/ja046275m
|
[16]
|
S. Giri, B. G. Trewyn and M. P. Stellmaker, “Stimuli- Responsive Controlled-Release Delivery System Based on Mesoporous Silica Nanorods Capped with Magnetic Nanoparticles,” Angewandte Chemie International Edition, Vol. 44, 2005, pp. 5038-5044.
doi:10.1002/anie.200501819
|
[17]
|
F. S. Xiao, S. H. Wang and P. W. Fan, “pH-Responsive Carrier System Based on Carboxylic Acid Modified Mesoporous Silica and Polye-lectrolyte for Drug Delivery,” Chemistry of Materials, Vol. 17, No. 24, 2005, pp. 5999-6003. doi:10.1021/cm051198v
|